1-6 of 6
Patricia Kalafut
Close
Sort by
Journal Articles

Disease Progression and Leukemic Transformation in Patients With Lower-Risk Myelofibrosis (MF): An Analysis from MOST

Rami S. Komrokji, Michael R. Grunwald, Evan Braunstein, J.E. Hamer-Maansson, Patricia Kalafut, John Mascarenhas
Journal: Blood
Blood (2022) 140 (Supplement 1): 6832–6834.
https://doi.org/10.1182/blood-2022-159181
Published: 2022
Journal Articles

Community Versus Academic Practice in Essential Thrombocythemia and Myelofibrosis: Differences in Clinical Characteristics, Diagnosis, Treatment Patterns, and Symptom Burden (Analysis of Data from the MOST Study)

Roger Lyons, David Lessen, Salman Fazal, Robyn Scherber, Patricia Kalafut, Haobo Ren, Ellen Ritchie
Journal: Blood
Blood (2021) 138 (Supplement 1): 1497.
https://doi.org/10.1182/blood-2021-145909
Published: 2021
Journal Articles

Clinical Characteristics and Treatment Patterns By Risk Stratification in Patients with Essential Thrombocythemia: An Analysis of the MOST Study

Michael R. Grunwald, MD, Ivy Altomare, MD, Robyn M. Scherber, MD, Patricia Kalafut, PhD, Haobo Ren, PhD, Srdan Verstovsek, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 12–13.
https://doi.org/10.1182/blood-2020-134841
Published: 2020
Journal Articles

To Treat or Not to Treat? Understanding Treatment Patterns in Patients with Lower-Risk Myelofibrosis at the Time of Enrollment in the MOST Study

Rami S. Komrokji, MD, Brady L. Stein, MD MHSc, Robyn M. Scherber, MD, Patricia Kalafut, PhD, Haobo Ren, PhD, Srdan Verstovsek, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 49–51.
https://doi.org/10.1182/blood-2020-134958
Published: 2020
Journal Articles

Patient-Reported Outcomes (PRO) Data from Patients (Pts) with Essential Thrombocythemia (ET) Enrolled in the MOST Study

Ellen K. Ritchie, MD, Anas Al-Janadi, MD, Philomena Colucci, DO, MS, Patricia Kalafut, PhD, Dilan Paranagama, PhD, Ruben A. Mesa, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1665.
https://doi.org/10.1182/blood-2019-124527
Published: 2019
Journal Articles

Disease and Clinical Characteristics of Patients with Myelofibrosis Enrolled in the MOST Study

Aaron T. Gerds, MD MS, Roger M. Lyons, MD, Philomena Colucci, DO, MS, Patricia Kalafut, PhD, Dilan Paranagama, PhD, Srdan Verstovsek, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4190.
https://doi.org/10.1182/blood-2019-122441
Published: 2019